Cervical cancer is emerging as a significant and troubling health concern in Canada, being described as the “fastest-rising form of cancer” in the country. This alarming trend was highlighted during a press conference held by the Society of Gynecologic Oncology of Canada in Ottawa, where experts urged the federal government to take decisive action. Despite a national action plan announced in July 2025, which aims to eliminate cervical cancer as a public health threat by 2040, health professionals insist that immediate measures are necessary to address this “silent national health crisis.”
A Growing Concern
Dr. Shannon Salvador, president of the Society of Gynecologic Oncology of Canada, revealed that in 2025, approximately 1,650 Canadians would receive a cervical cancer diagnosis, with an estimated 430 fatalities attributed to this largely preventable disease. “Canada is currently facing a silent national health crisis,” Dr. Salvador stated, emphasising the urgent need for improved prevention strategies. She pointed out that while advancements in modern medicine have been celebrated, the rates of cervical cancer diagnosis are inversely alarming.
The reliance on traditional Pap testing has proven inadequate in the face of rising incidence rates. Furthermore, vaccination against human papillomavirus (HPV), which is responsible for many cervical cancer cases, has not reached the levels necessary for effective prevention. The current vaccination completion rate stands at just 64 per cent, significantly below the targets needed for elimination. “This statistic is not merely a medical failure; it is a policy failure,” Dr. Salvador asserted.
Shifting the Focus to HPV Testing
In light of these challenges, the Society of Gynecologic Oncology of Canada is advocating for a fundamental shift towards HPV DNA testing for cervical cancer screening. They propose the immediate implementation of HPV self-collection kits, allowing individuals to perform tests at home. This approach aims to break down existing barriers to access, particularly for those living in rural or underserved communities.
As outlined by the Canadian Cancer Society, HPV testing can be conducted using swabs to collect samples from the cervix or vagina. Self-collection methods offer a practical solution that could significantly increase screening rates, especially for populations facing systemic obstacles in healthcare access. Dr. Salvador highlighted that these at-home kits could help those with limited mobility, trauma histories, or who lack a regular healthcare provider.
Addressing Disparities in Healthcare Access
The disparities affecting Indigenous women and other marginalised groups were also underscored during the press conference. Dr. Sarah Kean, the provincial lead for cervical cancer in Manitoba, noted that Indigenous women experience higher rates of diagnosis and more advanced stages of the disease. “This is not due to biological factors,” she explained, “but rather the result of barriers such as geographic isolation, systemic racism, and the long-lasting impacts of colonial practices.”
Dr. Kean called for robust and accessible HPV screening across Canada, emphasising the necessity for federal legislation to support widespread implementation. “Robust HPV screening must mean universal access across all provinces and territories with clear national standards,” she stated emphatically.
The Financial Burden of Cervical Cancer
The financial implications of cervical cancer for the Canadian healthcare system are substantial. In 2024, the cost of treating cervical cancer is projected to reach $132 million, while screening eligible Canadians would require an investment of $106 million over a five-year period. The urgency for a proactive approach is evident, particularly as the World Health Organization (WHO) aims to eliminate cervical cancer globally.
Despite previous declines in cervical cancer rates, the Canadian Cancer Society’s report in November 2025 indicated a worrying stagnation in progress. Cervical cancer remains a leading cause of cancer-related death among women, with a five-year survival rate of only 74 per cent. As noted by Dr. Kean, “All other cancers in our country are decreasing in incidence, except for the one that is entirely preventable.”
Why it Matters
The rising rates of cervical cancer in Canada highlight a critical failure in public health policy that demands immediate attention. Without swift action to improve vaccination rates and implement accessible screening solutions, countless lives are at risk. Addressing these disparities is not just a matter of healthcare; it is a moral imperative that reflects our commitment to equity in health outcomes for all Canadians. The time for action is now, as we strive to turn the tide on this preventable disease and ensure that every individual has the opportunity for early detection and treatment.
